Oral heroin in opioid-dependent patients: pharmacokinetic comparison of immediate and extended release tablets. Perger L, Rentsch KM, Kullak-Ublick GA, Verotta D, Fattinger K. Eur J Pharm Sci. 2009 Mar 2;36(4-5):421-32. doi: 10.1016/j.ejps.2008.11…

Treatment effectiveness of injectable hydromorphone and diacetylmorphine for severe opioid use disorder and its relationship with gender in the SALOME clinical trial Heather Palis, Lisbon Addictions 2017, Second European Conference on Addictive Beh…

Schweiz. Heroingestützte Behandlung in der Schweiz - Resultate der Erhebung 2016 Hiltebrand, Damian; Dey, Michelle; Bolliger, Heidi; Schaub, Michael P Zurich Open Repository and Archive, University of Zurich (ZORA), doi.org/10.5167/uzh-140487…

Heroin Assisted Treatment: the case for expanding uptake - Dr Alex Wodak puts forward the case to increase uptake of Heroin Assisted Treatment (“HAT”).  HAT has now been evaluated in trials involving a combined total of over 1…

Kanada. Guidance for Injectable Opioid Agonist Treatment for Opioid Use Disorder British Columbia, Ministry of Health and British Columbia Centre on Substance Abuse, 2101 http://www.bccsu.ca/wp-content/uploads/2017/10/BC-iOAT-Guidelines-10.2017.pdf

Why Australia should provide Heroin Assisted Treatment to severely dependent heroin users after all other treatment options haven’t worked. Heroin Assisted Treatment involves supervising prescribed pharmaceutical heroin self-administration wi…